Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes.

• Egile Nagusiak: Jiangyan Li (Egilea), Jie Zhang (Egilea), Qian Li (Egilea), Yue Hu (Egilea), Yonghua Ruan (Egilea), Zhiyong Tao (Egilea), Hui Xia (Egilea), Jichen Qiao (Egilea), Lingwen Meng (Egilea), Weilin Zeng (Egilea), Cuiying Li (Egilea), Xi He (Egilea), Luyi Zhao (Egilea), Faiza A Siddiqui (Egilea), Jun Miao (Egilea), Zhaoqing Yang (Egilea), Qiang Fang (Egilea), Liwang Cui (Egilea)
• Formatua: Liburua
• Argitaratua: Public Library of Science (PLoS), 2020-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

<h4>Background</h4>Vivax malaria is an important public health problem in the Greater Mekong Subregion (GMS), including the China-Myanmar border. Previous studies have found that Plasmodium vivax has decreased sensitivity to antimalarial drugs in some areas of the GMS, but the sensitivit...